|
1
|
Puppione DL: Higher primates, but not New
World monkeys, have a duplicate set of enhancers flanking their
ApoC-I genes. Comp Biochem Physiol Part D Genomics Proteomics.
11:45–48. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Puppione DL, Ryan CM, Bassilian S, Souda
P, Xiao X, Ryder OA and Whitelegge JP: Detection of two distinct
forms of ApoC-I in great apes. Comp Biochem Physiol Part D Genomics
Proteomics. 5:73–79. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Knott TJ, Robertson ME, Priestley LM,
Urdea M, Wallis S and Scott J: Characterisation of mRNAs encoding
the precursor for human apolipoprotein CI. Nucleic Acids Res.
12:3909–3915. 1984. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Sabatini DD, Kreibich G, Morimoto T and
Adesnik M: Mechanisms for the incorporation of proteins in
membranes and organelles. J Cell Biol. 92:1–22. 1982. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Jackson RL, Sparrow JT, Baker HN,
Morrisett JD, Taunton OD and Gotto AM Jr: The primary structure of
apolopoprotein-serine. J Biol Chem. 249:5308–5313. 1974.PubMed/NCBI
|
|
6
|
Shulman RS, Herbert PN, Wehrly K and
Fredrickson DS: Thf complete amino acid sequence of C-I
(apoLp-Ser), an apolipoprotein from human very low density
lipoproteins. J Biol Chem. 250:182–190. 1975.PubMed/NCBI
|
|
7
|
Bondarenko PV, Cockrill SL, Watkins LK,
Cruzado ID and Macfarlane RD: Mass spectral study of polymorphism
of the apolipoproteins of very low density lipoprotein. J Lipid
Res. 40:543–555. 1999.PubMed/NCBI
|
|
8
|
Gotoh H, Hagihara M, Nagatsu T, Iwata H
and Miura T: Activity of dipeptidyl peptidase IV and post-proline
cleaving enzyme in sera from osteoporotic patients. Clin Chem.
34:2499–2501. 1988.PubMed/NCBI
|
|
9
|
Krasteva V, Brodeur MR, Tremblay FL,
Falstrault L and Brissette L: Apolipoprotein C-I reduces
cholesteryl esters selective uptake from LDL and HDL by binding to
HepG2 cells and lipoproteins. Biochim Biophys Acta. 1801:42–48.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Westerterp M, Berbée JF, Delsing DJ, Jong
MC, Gijbels MJ, Dahlmans VE, Offerman EH, Romijn JA, Havekes LM and
Rensen PC: Apolipoprotein C-I binds free fatty acids and reduces
their intracellular esterification. J Lipid Res. 48:1353–1361.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ko HL, Wang YS, Fong WL, Chi MS, Chi KH
and Kao SJ: Apolipoprotein C1 (APOC1) as a novel diagnostic and
prognostic biomarker for lung cancer: A marker phase I trial.
Thorac Cancer. 5:500–508. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yamamoto-Ishikawa K, Suzuki H, Nezu M,
Kamiya N, Imamoto T, Komiya A, Sogawa K, Tomonaga T, Nomura F and
Ichikawa T: The isolation and identification of apolipoprotein C-I
in hormone-refractory prostate cancer using surface-enhanced laser
desorption/ionization time-of-flight mass spectrometry. Asian J
Androl. 11:299–307. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Takano S, Yoshitomi H, Togawa A, Sogawa K,
Shida T, Kimura F, Shimizu H, Tomonaga T, Nomura F and Miyazaki M:
Apolipoprotein C-1 maintains cell survival by preventing from
apoptosis in pancreatic cancer cells. Oncogene. 27:2810–2822. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhang J, Guo F, Wang L, Zhao W, Zhang D,
Yang H, Yu J, Niu L, Yang F, Zheng S, et al: Identification of
apolipoprotein C-I as a potential Wilms' tumor marker after
excluding inflammatory factors. Int J Mol Sci. 15:16186–16195.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Chang HH, Liu YL, Lu MY, Jou ST, Yang YL,
Lin DT, Lin KH1, Tzen KY, Yen RF, Lu CC, et al: A multidisciplinary
team care approach improves outcomes in high-risk pediatric
neuroblastoma patients. Oncotarget. 17:4360–4372. 2017.
|
|
16
|
Mao X, Chen Z, Zhao Y, Yu Y, Guan S,
Woodfield SE, Vasudevan SA, Tao L, Pang JC, Lu J, et al: Novel
multi-targeted ErbB family inhibitor afatinib blocks EGF-induced
signaling and induces apoptosis in neuroblastoma. Oncotarget.
8:1555–1568. 2017.PubMed/NCBI
|
|
17
|
Chen Z, Wang L, Yao D, Yang T, Cao WM, Dou
J, Pang JC, Guan S, Zhang H, Yu Y, et al: Wip1 inhibitor GSK2830371
inhibits neuroblastoma growth by inducing Chk2/p53-mediated
apoptosis. Sci Rep. 6:380112016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhang F, Kong DS, Zhang ZL, Lei N, Zhu XJ,
Zhang XP, Chen L, Lu Y and Zheng SZ: Tetramethylpyrazine induces
G0/G1 cell cycle arrest and stimulates mitochondrial-mediated and
caspase-dependent apoptosis through modulating ERK/p53 signaling in
hepatic stellate cells in vitro. Apoptosis. 18:135–149. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhao P, Han T, Guo JJ, Zhu SL, Wang J, Ao
F, Jing MZ, She YL, Wu ZH and Ye LB: HCV NS4B induces apoptosis
through the mitochondrial death pathway. Virus Res. 169:1–7. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Nagamine A, Hasegawa H, Hashimoto N,
Yamada-Inagawa T, Hirose M, Kobara Y, Tadokoro H, Kobayashi Y and
Takano H: The effects of DPP-4 inhibitor on hypoxia-induced
apoptosis in human umbilical vein endothelial cells. J Pharmacol
Sci. 133:42–48. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Xu L, Deng Y, Feng L, Li D, Chen X, Ma C,
Liu X, Yin J, Yang M, Teng F, et al: Cardio-protection of
salvianolic acid B through inhibition of apoptosis network. PLoS
One. 6:e240362011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Derakhshan A, Chen Z and Van Waes C:
Therapeutic small molecules target inhibitor of apoptosis proteins
in cancers with deregulation of extrinsic and intrinsic cell death
pathways. Clin Cancer Res. 23:1379–1387. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Cory S and Adams JM: The Bcl2 family:
Regulators of the cellular life-or-death switch. Nat Rev Cancer.
2:647–656. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
24
|
Murphy KM, Ranganathan V, Farnsworth ML,
Kavallaris M and Lock RB: Bcl-2 inhibits Bax translocation from
cytosol to mitochondria during drug-induced apoptosis of human
tumor cells. Cell Death Differ. 7:102–111. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Bouillet P, Purton JF, Godfrey DI, Zhang
LC, Coultas L, Puthalakath H, Pellegrini M, Cory S, Adams JM and
Strasser A: BH3-only Bcl-2 family member Bim is required for
apoptosis of autoreactive thymocytes. Nature. 415:922–926. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Whitfield J, Neame SJ, Paquet L, Bernard O
and Ham J: Dominant-negative c-Jun promotes neuronal survival by
reducing BIM expression and inhibiting mitochondrial cytochrome
c release. Neuron. 29:629–643. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
O'Connor L, Strasser A, O'Reilly LA,
Hausmann G, Adams JM, Cory S and Huang DC: Bim: A novel member of
the Bcl-2 family that promotes apoptosis. EMBO J. 17:384–395. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ley R, Balmanno K, Hadfield K, Weston C
and Cook SJ: Activation of the ERK1/2 signaling pathway promotes
phosphorylation and proteasome-dependent degradation of the
BH3-only protein, Bim. J Biol Chem. 278:18811–18816. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Lei K and Davis RJ: JNK phosphorylation of
Bim-related members of the Bcl2 family induces Bax-dependent
apoptosis. Proc Natl Acad Sci USA. 100:2432–2437. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Liu JW, Chandra D, Tang SH, Chopra D and
Tang DG: Identification and characterization of Bimgamma, a novel
proapoptotic BH3-only splice variant of Bim. Cancer Res.
62:2976–2981. 2002.PubMed/NCBI
|
|
31
|
Wei H, Li Z, Hu S, Chen X and Cong X:
Apoptosis of mesenchymal stem cells induced by hydrogen peroxide
concerns both endoplasmic reticulum stress and mitochondrial death
pathway through regulation of caspases, p38 and JNK. J Cell
Biochem. 111:967–978. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Zou H, Li Y, Liu X and Wang X: An
APAF-1.cytochrome c multimeric complex is a functional
apoptosome that activates procaspase-9. J Biol Chem.
274:11549–11556. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Strasser A, Jost PJ and Nagata S: The many
roles of FAS receptor signaling in the immune system. Immunity.
30:180–192. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Wei MC, Zong WX, Cheng EH, Lindsten T,
Panoutsakopoulou V, Ross AJ, Roth KA, MacGregor GR, Thompson CB and
Korsmeyer SJ: Proapoptotic BAX and BAK: A requisite gateway to
mitochondrial dysfunction and death. Science. 292:727–730. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Korsmeyer SJ, Wei MC, Saito M, Weiler S,
Oh KJ and Schlesinger PH: Pro-apoptotic cascade activates BID,
which oligomerizes BAK or BAX into pores that result in the release
of cytochrome c. Cell Death Differ. 7:1166–1173. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Bus P, Pierneef L, Bor R, Wolterbeek R,
van Es LA, Rensen PC, de Heer E, Havekes LM, Bruijn JA, Berbée JF,
et al: Apolipoprotein C-I plays a role in the pathogenesis of
glomerulosclerosis. J Pathol. 241:589–599. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Berbée JF, van der Hoogt CC, Kleemann R,
Schippers EF, Kitchens RL, van Dissel JT, Bakker-Woudenberg IA,
Havekes LM and Rensen PC: Apolipoprotein CI stimulates the response
to lipopolysaccharide and reduces mortality in gram-negative
sepsis. FASEB J. 20:2162–2164. 2006. View Article : Google Scholar : PubMed/NCBI
|
